nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—chronic obstructive pulmonary disease	0.34	1	CbGaD
Tacrolimus—ALB—Prednisone—chronic obstructive pulmonary disease	0.0382	0.179	CbGbCtD
Tacrolimus—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0376	0.177	CbGbCtD
Tacrolimus—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0254	0.119	CbGbCtD
Tacrolimus—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0242	0.114	CbGbCtD
Tacrolimus—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0216	0.102	CbGbCtD
Tacrolimus—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0212	0.0994	CbGbCtD
Tacrolimus—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.02	0.0939	CbGbCtD
Tacrolimus—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0127	0.0596	CbGbCtD
Tacrolimus—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.012	0.0562	CbGbCtD
Tacrolimus—MTOR—leg—chronic obstructive pulmonary disease	0.0114	0.17	CbGeAlD
Tacrolimus—ABCA5—bronchus—chronic obstructive pulmonary disease	0.00465	0.0697	CbGeAlD
Tacrolimus—ABCA5—trachea—chronic obstructive pulmonary disease	0.00418	0.0626	CbGeAlD
Tacrolimus—PPP3CA—respiratory system—chronic obstructive pulmonary disease	0.00382	0.0572	CbGeAlD
Tacrolimus—PPP3CA—connective tissue—chronic obstructive pulmonary disease	0.00336	0.0504	CbGeAlD
Tacrolimus—PPP3CA—bronchus—chronic obstructive pulmonary disease	0.00314	0.0471	CbGeAlD
Tacrolimus—PPP3CA—smooth muscle tissue—chronic obstructive pulmonary disease	0.00307	0.0461	CbGeAlD
Tacrolimus—ABCA5—lung—chronic obstructive pulmonary disease	0.003	0.045	CbGeAlD
Tacrolimus—PPP3CA—trachea—chronic obstructive pulmonary disease	0.00282	0.0423	CbGeAlD
Tacrolimus—MTOR—respiratory system—chronic obstructive pulmonary disease	0.00282	0.0423	CbGeAlD
Tacrolimus—FKBP1A—respiratory system—chronic obstructive pulmonary disease	0.00254	0.038	CbGeAlD
Tacrolimus—MTOR—connective tissue—chronic obstructive pulmonary disease	0.00248	0.0372	CbGeAlD
Tacrolimus—MTOR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00227	0.0341	CbGeAlD
Tacrolimus—FKBP1A—connective tissue—chronic obstructive pulmonary disease	0.00223	0.0335	CbGeAlD
Tacrolimus—FKBP1A—bronchus—chronic obstructive pulmonary disease	0.00209	0.0313	CbGeAlD
Tacrolimus—FKBP1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00204	0.0306	CbGeAlD
Tacrolimus—PPP3CA—lung—chronic obstructive pulmonary disease	0.00203	0.0304	CbGeAlD
Tacrolimus—FKBP1A—trachea—chronic obstructive pulmonary disease	0.00187	0.0281	CbGeAlD
Tacrolimus—MTOR—lung—chronic obstructive pulmonary disease	0.0015	0.0225	CbGeAlD
Tacrolimus—FKBP1A—lung—chronic obstructive pulmonary disease	0.00135	0.0202	CbGeAlD
Tacrolimus—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.0011	0.0166	CbGeAlD
Tacrolimus—ORM1—lung—chronic obstructive pulmonary disease	0.00105	0.0158	CbGeAlD
Tacrolimus—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000587	0.0088	CbGeAlD
Tacrolimus—CYP3A5—lung—chronic obstructive pulmonary disease	0.000586	0.00879	CbGeAlD
Tacrolimus—ABCB1—trachea—chronic obstructive pulmonary disease	0.000434	0.0065	CbGeAlD
Tacrolimus—ABCB1—lung—chronic obstructive pulmonary disease	0.000312	0.00467	CbGeAlD
Tacrolimus—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000547	CcSEcCtD
Tacrolimus—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000547	CcSEcCtD
Tacrolimus—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000543	CcSEcCtD
Tacrolimus—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000541	CcSEcCtD
Tacrolimus—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000541	CcSEcCtD
Tacrolimus—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00054	CcSEcCtD
Tacrolimus—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.000538	CcSEcCtD
Tacrolimus—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000538	CcSEcCtD
Tacrolimus—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000537	CcSEcCtD
Tacrolimus—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000536	CcSEcCtD
Tacrolimus—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000535	CcSEcCtD
Tacrolimus—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000533	CcSEcCtD
Tacrolimus—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000533	CcSEcCtD
Tacrolimus—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000531	CcSEcCtD
Tacrolimus—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.000528	CcSEcCtD
Tacrolimus—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000528	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000527	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000527	CcSEcCtD
Tacrolimus—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000524	CcSEcCtD
Tacrolimus—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000524	CcSEcCtD
Tacrolimus—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000521	CcSEcCtD
Tacrolimus—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.00052	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000517	CcSEcCtD
Tacrolimus—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000145	0.000516	CcSEcCtD
Tacrolimus—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.000516	CcSEcCtD
Tacrolimus—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.000515	CcSEcCtD
Tacrolimus—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000144	0.000515	CcSEcCtD
Tacrolimus—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000513	CcSEcCtD
Tacrolimus—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000511	CcSEcCtD
Tacrolimus—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000511	CcSEcCtD
Tacrolimus—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00051	CcSEcCtD
Tacrolimus—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00051	CcSEcCtD
Tacrolimus—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000509	CcSEcCtD
Tacrolimus—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.000507	CcSEcCtD
Tacrolimus—Injury—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000504	CcSEcCtD
Tacrolimus—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000504	CcSEcCtD
Tacrolimus—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.000503	CcSEcCtD
Tacrolimus—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000502	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.0005	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00014	0.0005	CcSEcCtD
Tacrolimus—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000499	CcSEcCtD
Tacrolimus—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000499	CcSEcCtD
Tacrolimus—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000499	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000498	CcSEcCtD
Tacrolimus—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000495	CcSEcCtD
Tacrolimus—Pain—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000495	CcSEcCtD
Tacrolimus—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000495	CcSEcCtD
Tacrolimus—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000495	CcSEcCtD
Tacrolimus—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000494	CcSEcCtD
Tacrolimus—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000493	CcSEcCtD
Tacrolimus—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000493	CcSEcCtD
Tacrolimus—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000491	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000489	CcSEcCtD
Tacrolimus—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000489	CcSEcCtD
Tacrolimus—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000487	CcSEcCtD
Tacrolimus—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000486	CcSEcCtD
Tacrolimus—Pain—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000485	CcSEcCtD
Tacrolimus—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000485	CcSEcCtD
Tacrolimus—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.000484	CcSEcCtD
Tacrolimus—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000482	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000482	CcSEcCtD
Tacrolimus—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000481	CcSEcCtD
Tacrolimus—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.00048	CcSEcCtD
Tacrolimus—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.000479	CcSEcCtD
Tacrolimus—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000478	CcSEcCtD
Tacrolimus—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000477	CcSEcCtD
Tacrolimus—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000477	CcSEcCtD
Tacrolimus—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.000476	CcSEcCtD
Tacrolimus—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000475	CcSEcCtD
Tacrolimus—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000475	CcSEcCtD
Tacrolimus—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.000474	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000473	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000473	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000472	CcSEcCtD
Tacrolimus—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000471	CcSEcCtD
Tacrolimus—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000467	CcSEcCtD
Tacrolimus—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000467	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00013	0.000464	CcSEcCtD
Tacrolimus—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000463	CcSEcCtD
Tacrolimus—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000463	CcSEcCtD
Tacrolimus—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00046	CcSEcCtD
Tacrolimus—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00046	CcSEcCtD
Tacrolimus—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000458	CcSEcCtD
Tacrolimus—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000458	CcSEcCtD
Tacrolimus—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000458	CcSEcCtD
Tacrolimus—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000458	CcSEcCtD
Tacrolimus—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000456	CcSEcCtD
Tacrolimus—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.000456	CcSEcCtD
Tacrolimus—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000453	CcSEcCtD
Tacrolimus—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000452	CcSEcCtD
Tacrolimus—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000452	CcSEcCtD
Tacrolimus—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.000452	CcSEcCtD
Tacrolimus—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00045	CcSEcCtD
Tacrolimus—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00045	CcSEcCtD
Tacrolimus—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.000449	CcSEcCtD
Tacrolimus—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000449	CcSEcCtD
Tacrolimus—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000448	CcSEcCtD
Tacrolimus—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000448	CcSEcCtD
Tacrolimus—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000447	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000447	CcSEcCtD
Tacrolimus—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000443	CcSEcCtD
Tacrolimus—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000441	CcSEcCtD
Tacrolimus—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000441	CcSEcCtD
Tacrolimus—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000439	CcSEcCtD
Tacrolimus—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000434	CcSEcCtD
Tacrolimus—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000432	CcSEcCtD
Tacrolimus—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000432	CcSEcCtD
Tacrolimus—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000426	CcSEcCtD
Tacrolimus—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000426	CcSEcCtD
Tacrolimus—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.000426	CcSEcCtD
Tacrolimus—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000425	CcSEcCtD
Tacrolimus—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000425	CcSEcCtD
Tacrolimus—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000422	CcSEcCtD
Tacrolimus—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000418	CcSEcCtD
Tacrolimus—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000415	CcSEcCtD
Tacrolimus—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000415	CcSEcCtD
Tacrolimus—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00041	CcSEcCtD
Tacrolimus—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00041	CcSEcCtD
Tacrolimus—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000409	CcSEcCtD
Tacrolimus—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000407	CcSEcCtD
Tacrolimus—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000403	CcSEcCtD
Tacrolimus—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000403	CcSEcCtD
Tacrolimus—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000401	CcSEcCtD
Tacrolimus—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000396	CcSEcCtD
Tacrolimus—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000396	CcSEcCtD
Tacrolimus—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000394	CcSEcCtD
Tacrolimus—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000393	CcSEcCtD
Tacrolimus—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000392	CcSEcCtD
Tacrolimus—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00039	CcSEcCtD
Tacrolimus—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000388	CcSEcCtD
Tacrolimus—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000387	CcSEcCtD
Tacrolimus—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000384	CcSEcCtD
Tacrolimus—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000383	CcSEcCtD
Tacrolimus—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000383	CcSEcCtD
Tacrolimus—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000375	CcSEcCtD
Tacrolimus—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000375	CcSEcCtD
Tacrolimus—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000374	CcSEcCtD
Tacrolimus—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000368	CcSEcCtD
Tacrolimus—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000368	CcSEcCtD
Tacrolimus—Rash—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000365	CcSEcCtD
Tacrolimus—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000365	CcSEcCtD
Tacrolimus—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000365	CcSEcCtD
Tacrolimus—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000365	CcSEcCtD
Tacrolimus—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000365	CcSEcCtD
Tacrolimus—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000363	CcSEcCtD
Tacrolimus—Headache—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000363	CcSEcCtD
Tacrolimus—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000362	CcSEcCtD
Tacrolimus—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000362	CcSEcCtD
Tacrolimus—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000361	CcSEcCtD
Tacrolimus—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000361	CcSEcCtD
Tacrolimus—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00036	CcSEcCtD
Tacrolimus—Rash—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000357	CcSEcCtD
Tacrolimus—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0001	0.000357	CcSEcCtD
Tacrolimus—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.99e-05	0.000356	CcSEcCtD
Tacrolimus—Depression—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000356	CcSEcCtD
Tacrolimus—Headache—Montelukast—chronic obstructive pulmonary disease	9.95e-05	0.000355	CcSEcCtD
Tacrolimus—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000352	CcSEcCtD
Tacrolimus—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.00035	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.00035	CcSEcCtD
Tacrolimus—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.74e-05	0.000348	CcSEcCtD
Tacrolimus—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.71e-05	0.000346	CcSEcCtD
Tacrolimus—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.67e-05	0.000345	CcSEcCtD
Tacrolimus—Rash—Salbutamol—chronic obstructive pulmonary disease	9.66e-05	0.000345	CcSEcCtD
Tacrolimus—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.65e-05	0.000344	CcSEcCtD
Tacrolimus—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.65e-05	0.000344	CcSEcCtD
Tacrolimus—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.64e-05	0.000344	CcSEcCtD
Tacrolimus—Nausea—Formoterol—chronic obstructive pulmonary disease	9.64e-05	0.000344	CcSEcCtD
Tacrolimus—Headache—Salbutamol—chronic obstructive pulmonary disease	9.6e-05	0.000342	CcSEcCtD
Tacrolimus—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.000338	CcSEcCtD
Tacrolimus—Nausea—Montelukast—chronic obstructive pulmonary disease	9.44e-05	0.000337	CcSEcCtD
Tacrolimus—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.33e-05	0.000333	CcSEcCtD
Tacrolimus—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.29e-05	0.000332	CcSEcCtD
Tacrolimus—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000326	CcSEcCtD
Tacrolimus—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.1e-05	0.000325	CcSEcCtD
Tacrolimus—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.05e-05	0.000323	CcSEcCtD
Tacrolimus—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.03e-05	0.000322	CcSEcCtD
Tacrolimus—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.99e-05	0.000321	CcSEcCtD
Tacrolimus—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000319	CcSEcCtD
Tacrolimus—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000315	CcSEcCtD
Tacrolimus—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.79e-05	0.000313	CcSEcCtD
Tacrolimus—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.79e-05	0.000313	CcSEcCtD
Tacrolimus—Shock—Prednisolone—chronic obstructive pulmonary disease	8.64e-05	0.000308	CcSEcCtD
Tacrolimus—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.57e-05	0.000306	CcSEcCtD
Tacrolimus—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000303	CcSEcCtD
Tacrolimus—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.0003	CcSEcCtD
Tacrolimus—Flushing—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000298	CcSEcCtD
Tacrolimus—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000291	CcSEcCtD
Tacrolimus—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.00029	CcSEcCtD
Tacrolimus—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000286	CcSEcCtD
Tacrolimus—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.95e-05	0.000284	CcSEcCtD
Tacrolimus—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000283	CcSEcCtD
Tacrolimus—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.89e-05	0.000281	CcSEcCtD
Tacrolimus—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.000281	CcSEcCtD
Tacrolimus—Erythema—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000279	CcSEcCtD
Tacrolimus—Malnutrition—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000279	CcSEcCtD
Tacrolimus—Pain—Prednisolone—chronic obstructive pulmonary disease	7.51e-05	0.000268	CcSEcCtD
Tacrolimus—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000263	CcSEcCtD
Tacrolimus—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000259	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.24e-05	0.000258	CcSEcCtD
Tacrolimus—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.23e-05	0.000258	CcSEcCtD
Tacrolimus—Agitation—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000257	CcSEcCtD
Tacrolimus—Malaise—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000252	CcSEcCtD
Tacrolimus—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000251	CcSEcCtD
Tacrolimus—Syncope—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.00025	CcSEcCtD
Tacrolimus—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.98e-05	0.000249	CcSEcCtD
Tacrolimus—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.88e-05	0.000245	CcSEcCtD
Tacrolimus—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000242	CcSEcCtD
Tacrolimus—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000241	CcSEcCtD
Tacrolimus—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000238	CcSEcCtD
Tacrolimus—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000238	CcSEcCtD
Tacrolimus—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.64e-05	0.000237	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000236	CcSEcCtD
Tacrolimus—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.000235	CcSEcCtD
Tacrolimus—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.47e-05	0.000231	CcSEcCtD
Tacrolimus—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000228	CcSEcCtD
Tacrolimus—Oedema—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000228	CcSEcCtD
Tacrolimus—Infection—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000226	CcSEcCtD
Tacrolimus—Shock—Prednisone—chronic obstructive pulmonary disease	6.28e-05	0.000224	CcSEcCtD
Tacrolimus—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000223	CcSEcCtD
Tacrolimus—MTOR—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	6.24e-05	0.00062	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	6.24e-05	0.000619	CbGpPWpGaD
Tacrolimus—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000222	CcSEcCtD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	6.21e-05	0.000617	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	6.21e-05	0.000617	CbGpPWpGaD
Tacrolimus—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000221	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	6.18e-05	0.000614	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.17e-05	0.000613	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.00022	CcSEcCtD
Tacrolimus—MTOR—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	6.15e-05	0.000611	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.1e-05	0.000606	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	6.1e-05	0.000606	CbGpPWpGaD
Tacrolimus—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000217	CcSEcCtD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	6.06e-05	0.000602	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TLR4—chronic obstructive pulmonary disease	6.06e-05	0.000602	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.97e-05	0.000593	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.96e-05	0.000592	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.96e-05	0.000592	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.92e-05	0.000587	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.91e-05	0.000587	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.000208	CcSEcCtD
Tacrolimus—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.81e-05	0.000207	CcSEcCtD
Tacrolimus—MTOR—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	5.79e-05	0.000575	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	5.79e-05	0.000575	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	5.79e-05	0.000575	CbGpPWpGaD
Tacrolimus—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.000206	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	5.75e-05	0.000571	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	5.75e-05	0.000571	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	5.74e-05	0.00057	CbGpPWpGaD
Tacrolimus—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000205	CcSEcCtD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	5.69e-05	0.000565	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	5.68e-05	0.000564	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	5.66e-05	0.000562	CbGpPWpGaD
Tacrolimus—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000201	CcSEcCtD
Tacrolimus—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	5.55e-05	0.000552	CbGpPWpGaD
Tacrolimus—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000198	CcSEcCtD
Tacrolimus—Rash—Prednisolone—chronic obstructive pulmonary disease	5.54e-05	0.000198	CcSEcCtD
Tacrolimus—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.53e-05	0.000197	CcSEcCtD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.52e-05	0.000548	CbGpPWpGaD
Tacrolimus—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000196	CcSEcCtD
Tacrolimus—Headache—Prednisolone—chronic obstructive pulmonary disease	5.5e-05	0.000196	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.5e-05	0.000546	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	5.48e-05	0.000544	CbGpPWpGaD
Tacrolimus—Constipation—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000195	CcSEcCtD
Tacrolimus—MTOR—B Cell Activation—EGFR—chronic obstructive pulmonary disease	5.36e-05	0.000532	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.34e-05	0.000531	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	5.34e-05	0.000531	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	5.34e-05	0.00053	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS2—chronic obstructive pulmonary disease	5.32e-05	0.000528	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	5.28e-05	0.000524	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000188	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	5.26e-05	0.000522	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000186	CcSEcCtD
Tacrolimus—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.22e-05	0.000186	CcSEcCtD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	5.22e-05	0.000518	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	5.21e-05	0.000518	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	5.18e-05	0.000514	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—EGFR—chronic obstructive pulmonary disease	5.16e-05	0.000512	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.13e-05	0.000509	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	5.13e-05	0.000509	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	5.11e-05	0.000507	CbGpPWpGaD
Tacrolimus—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000181	CcSEcCtD
Tacrolimus—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.06e-05	0.000502	CbGpPWpGaD
Tacrolimus—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.00018	CcSEcCtD
Tacrolimus—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.00018	CcSEcCtD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	5.03e-05	0.000499	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.97e-05	0.000494	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	4.97e-05	0.000494	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ERBB3—chronic obstructive pulmonary disease	4.95e-05	0.000491	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.92e-05	0.000488	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.87e-05	0.000483	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.85e-05	0.000481	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.81e-05	0.000478	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	4.8e-05	0.000477	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	4.78e-05	0.000474	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	4.75e-05	0.000472	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.75e-05	0.000471	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.74e-05	0.000471	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CRP—chronic obstructive pulmonary disease	4.73e-05	0.00047	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—chronic obstructive pulmonary disease	4.73e-05	0.00047	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000168	CcSEcCtD
Tacrolimus—MTOR—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	4.67e-05	0.000464	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.62e-05	0.000459	CbGpPWpGaD
Tacrolimus—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000163	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—TLR4—chronic obstructive pulmonary disease	4.54e-05	0.000451	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.53e-05	0.000449	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.52e-05	0.000449	CbGpPWpGaD
Tacrolimus—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.52e-05	0.000161	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.5e-05	0.000447	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—SERPINE1—chronic obstructive pulmonary disease	4.48e-05	0.000445	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.47e-05	0.000444	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	4.45e-05	0.000442	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	4.45e-05	0.000442	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—chronic obstructive pulmonary disease	4.45e-05	0.000442	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	4.41e-05	0.000438	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	4.37e-05	0.000434	CbGpPWpGaD
Tacrolimus—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000156	CcSEcCtD
Tacrolimus—MTOR—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	4.35e-05	0.000432	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.3e-05	0.000427	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS3—chronic obstructive pulmonary disease	4.28e-05	0.000425	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.28e-05	0.000425	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR2—chronic obstructive pulmonary disease	4.28e-05	0.000425	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.27e-05	0.000424	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.27e-05	0.000424	CbGpPWpGaD
Tacrolimus—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000151	CcSEcCtD
Tacrolimus—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.22e-05	0.000419	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	4.16e-05	0.000413	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS2—chronic obstructive pulmonary disease	4.13e-05	0.00041	CbGpPWpGaD
Tacrolimus—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.06e-05	0.000145	CcSEcCtD
Tacrolimus—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.05e-05	0.000403	CbGpPWpGaD
Tacrolimus—Rash—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000144	CcSEcCtD
Tacrolimus—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000144	CcSEcCtD
Tacrolimus—MTOR—Immune System—KL—chronic obstructive pulmonary disease	4.02e-05	0.000399	CbGpPWpGaD
Tacrolimus—Headache—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000143	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4e-05	0.000397	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HDAC2—chronic obstructive pulmonary disease	3.99e-05	0.000397	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—chronic obstructive pulmonary disease	3.96e-05	0.000394	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.96e-05	0.000393	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.000392	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—chronic obstructive pulmonary disease	3.94e-05	0.000392	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.94e-05	0.000391	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.93e-05	0.00039	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.88e-05	0.000385	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.86e-05	0.000384	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.85e-05	0.000382	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.82e-05	0.00038	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.82e-05	0.00038	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.81e-05	0.000379	CbGpPWpGaD
Tacrolimus—Nausea—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000135	CcSEcCtD
Tacrolimus—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.73e-05	0.00037	CbGpPWpGaD
Tacrolimus—MTOR—Disease—KL—chronic obstructive pulmonary disease	3.71e-05	0.000369	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.68e-05	0.000365	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.68e-05	0.000365	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.65e-05	0.000363	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.65e-05	0.000362	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.58e-05	0.000355	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	3.53e-05	0.000351	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—SERPINE1—chronic obstructive pulmonary disease	3.47e-05	0.000345	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.47e-05	0.000344	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.34e-05	0.000331	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.33e-05	0.00033	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS3—chronic obstructive pulmonary disease	3.32e-05	0.000329	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.29e-05	0.000327	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD8A—chronic obstructive pulmonary disease	3.24e-05	0.000322	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	3.23e-05	0.000321	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.22e-05	0.00032	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.14e-05	0.000312	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.14e-05	0.000312	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.14e-05	0.000311	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	3.1e-05	0.000308	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.1e-05	0.000308	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—chronic obstructive pulmonary disease	3.03e-05	0.000301	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB3—chronic obstructive pulmonary disease	3.01e-05	0.000299	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—EGFR—chronic obstructive pulmonary disease	3e-05	0.000298	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3e-05	0.000298	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3e-05	0.000298	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.92e-05	0.00029	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.85e-05	0.000283	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.83e-05	0.000281	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—chronic obstructive pulmonary disease	2.83e-05	0.000281	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.8e-05	0.000278	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB3—chronic obstructive pulmonary disease	2.78e-05	0.000276	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—EGFR—chronic obstructive pulmonary disease	2.77e-05	0.000275	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—chronic obstructive pulmonary disease	2.76e-05	0.000274	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.66e-05	0.000264	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.000263	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.65e-05	0.000263	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR4—chronic obstructive pulmonary disease	2.64e-05	0.000262	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.61e-05	0.000259	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.000259	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.61e-05	0.000259	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.6e-05	0.000258	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.56e-05	0.000255	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.53e-05	0.000251	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.5e-05	0.000248	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.43e-05	0.000242	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.43e-05	0.000241	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.4e-05	0.000239	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.4e-05	0.000238	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.39e-05	0.000238	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.36e-05	0.000234	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.35e-05	0.000233	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.32e-05	0.000231	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—chronic obstructive pulmonary disease	2.32e-05	0.00023	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—chronic obstructive pulmonary disease	2.31e-05	0.000229	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.27e-05	0.000225	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EGFR—chronic obstructive pulmonary disease	2.25e-05	0.000223	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.24e-05	0.000223	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.23e-05	0.000222	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—chronic obstructive pulmonary disease	2.19e-05	0.000218	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.18e-05	0.000216	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	2.16e-05	0.000215	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.16e-05	0.000214	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EGFR—chronic obstructive pulmonary disease	2.15e-05	0.000214	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.15e-05	0.000213	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.14e-05	0.000213	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—chronic obstructive pulmonary disease	2.13e-05	0.000212	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.06e-05	0.000205	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.05e-05	0.000203	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2e-05	0.000199	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.000197	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.98e-05	0.000197	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.98e-05	0.000197	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.97e-05	0.000196	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.96e-05	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SERPINE1—chronic obstructive pulmonary disease	1.95e-05	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.95e-05	0.000194	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.94e-05	0.000193	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.93e-05	0.000192	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000192	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.000188	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000188	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.000187	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.88e-05	0.000186	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS3—chronic obstructive pulmonary disease	1.87e-05	0.000185	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.86e-05	0.000185	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000178	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.76e-05	0.000175	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.74e-05	0.000173	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.73e-05	0.000172	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—chronic obstructive pulmonary disease	1.72e-05	0.000171	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.71e-05	0.00017	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.69e-05	0.000168	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.67e-05	0.000166	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—chronic obstructive pulmonary disease	1.65e-05	0.000164	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.63e-05	0.000162	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.62e-05	0.000161	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.57e-05	0.000156	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.000154	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000153	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.54e-05	0.000153	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.51e-05	0.00015	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.5e-05	0.000149	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.49e-05	0.000148	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.000144	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.42e-05	0.000141	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.000136	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.37e-05	0.000136	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.36e-05	0.000135	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.36e-05	0.000135	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.34e-05	0.000133	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EGFR—chronic obstructive pulmonary disease	1.31e-05	0.00013	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.00013	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.29e-05	0.000128	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.26e-05	0.000126	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.25e-05	0.000124	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.25e-05	0.000124	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—chronic obstructive pulmonary disease	1.23e-05	0.000123	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.23e-05	0.000122	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EGFR—chronic obstructive pulmonary disease	1.21e-05	0.00012	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000118	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.000117	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.17e-05	0.000116	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.000115	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.16e-05	0.000115	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.09e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000105	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.05e-05	0.000104	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000104	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000103	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.03e-05	0.000102	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—chronic obstructive pulmonary disease	1.01e-05	0.0001	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.52e-06	9.45e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.41e-06	9.35e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	9.32e-06	9.25e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—chronic obstructive pulmonary disease	9.3e-06	9.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	8.91e-06	8.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.77e-06	8.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.64e-06	8.58e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.47e-06	8.41e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	7.68e-06	7.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.32e-06	7.27e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.22e-06	7.17e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.11e-06	7.06e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	7.03e-06	6.98e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.73e-06	6.68e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.72e-06	6.68e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.51e-06	6.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.37e-06	6.33e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.33e-06	4.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.14e-06	4.12e-05	CbGpPWpGaD
